InsidersTradesSigma
Follow the 삼성제약 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 삼성제약 has published 2 public disclosures. Market capitalisation: €111.1bn. The latest transaction was reported on 11 March 2026 (Other). Among the most active insiders: 삼성제약. The full history is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Samsung Pharmaceutical es una empresa surcoreana especializada en el sector de la salud y farmacéutico. Cotiza en el KRX.